Structural basis for differential binding of the interleukin-8 monomer and dimer to the CXCR1 N-domain: role of coupled interactions and dynamics.
Interleukin-8 (IL-8 or CXCL8) plays a critical role in orchestrating the immune response by binding and activating the receptor CXCR1 that belongs to the GPCR class. IL-8 exists as both monomers and dimers, and both bind CXCR1 but with differential affinities. It is well established that the monomer is the high-affinity ligand and that the interactions between the ligand N-loop and receptor N-domain play a critical role in determining binding affinity. In order to characterize the structural basis of differential binding of the IL-8 monomer and dimer to the CXCR1 N-domain, we analyzed binding-induced NMR chemical shift and peak intensity changes and show that they are exquisitely sensitive and can provide detailed insights into the binding process. We used three IL-8 variants, a designed monomer, a trapped disulfide-linked dimer, and WT at dimeric concentrations. NMR data for the monomer show that nonsequential residues that span the entire N-loop are involved in the binding process and that the binding is mediated by a network of extensive direct and indirect coupled interactions. Interestingly, in the case of WT, binding induces dissociation of the dimer-receptor complex to the monomer-receptor complex, and in the case of the trapped dimer, binding results in increased global conformational flexibility. Increased dynamics is evidence of unfavorable interactions, indicating that binding of the WT dimer triggers conformational changes that disrupt dimer-interface interactions, resulting in its dissociation. These results together provide evidence that binding is not a localized event but results in extensive coupled interactions within the monomer and across the dimer interface and that these interactions play a fundamental role in determining binding affinity.
Ravindran
Aishwarya
A
Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, 5.142 Medical Research Building, 301 University Boulevard, The University of Texas Medical Branch, Galveston, Texas 77555, USA.
Joseph
Prem Raj B
PR
Rajarathnam
Krishna
K
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution / Q000235:genetics; D006801:Humans; D016209:Interleukin-8 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding / Q000235:genetics; D025941:Protein Interaction Mapping; D055503:Protein Multimerization / Q000235:genetics; D017434:Protein Structure, Tertiary / Q000235:genetics; D023062:Receptors, Interleukin-8A / Q000737:chemistry* / Q000378:metabolism*; D013499:Surface Properties; D013816:Thermodynamics
D016209:Interleukin-8; D010446:Peptide Fragments; D023062:Receptors, Interleukin-8A
Curr Opin Immunol. 2002 Feb;14(1):129-35
11790543
J Biol Chem. 1991 Dec 5;266(34):23128-34
1744111
J Biomol NMR. 1994 Sep;4(5):603-14
22911360
Nucleic Acids Res. 2003 Jul 1;31(13):3316-9
12824316
J Biol Chem. 1995 May 5;270(18):10428-31
7737976
J Biol Chem. 1996 Apr 5;271(14):8228-35
8626516
Biochemistry. 1998 Aug 11;37(32):11193-201
9698365
J Biol Chem. 2000 Sep 1;275(35):27250-7
10859315
Biochemistry. 2000 Jul 25;39(29):8382-95
10913244
Biochemistry. 1999 Feb 2;38(5):1402-14
9931005
J Biol Chem. 2007 Sep 21;282(38):27976-83
17644519
Nat Immunol. 2001 Feb;2(2):108-15
11175802
Biochemistry. 1994 Nov 1;33(43):12741-5
7947677
Sci Signal. 2008 Sep 16;1(37):ra4
18799424
J Biol Chem. 2004 Jul 16;279(29):30000-8
15133028
Trends Immunol. 2004 Feb;25(2):75-84
15102366
J Biol Chem. 2004 Aug 27;279(35):36175-8
15252057
Structure. 1999 Feb 15;7(2):157-68
10368283
Biochemistry. 1990 Feb 20;29(7):1689-96
2184886
Biochemistry. 2002 Aug 20;41(33):10418-25
12173928
J Biol Chem. 1996 Jun 14;271(24):14344-52
8662882
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8868-73
10908673
J Biomol NMR. 2006 Dec;36(4):215-24
17061025
J Mol Biol. 2006 Jun 23;359(5):1400-9
16725153
Methods Enzymol. 2001;339:377-89
11462822
Methods Enzymol. 1997;287:89-105
9330317
J Biol Chem. 1992 Dec 15;267(35):25402-6
1281158
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
N Engl J Med. 1998 Feb 12;338(7):436-45
9459648
FEBS J. 2007 Jan;274(1):241-51
17222184
EMBO J. 1997 Dec 1;16(23):6996-7007
9384579
J Biol Chem. 1994 Jul 29;269(30):19343-8
8034699
Curr Pharm Des. 2002;8(24):2159-69
12369860
J Mol Biol. 2007 Jan 26;365(4):1063-75
17101151
Biosci Rep. 2006 Oct;26(5):325-39
17024562
Biochemistry. 1994 May 17;33(19):5984-6003
7514039
J Biol Chem. 1994 Jun 10;269(23):16075-81
8206907
Biochemistry. 1999 Jun 15;38(24):7653-8
10387004
Biochemistry. 2006 Jun 27;45(25):7882-8
16784240
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1885-90
12571364
J Biol Chem. 1993 Apr 5;268(10):7283-9
8463264
J Mol Biol. 1993 Mar 20;230(2):364-72
8464050
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3574-7
8475106
J Immunol. 1995 Sep 1;155(5):2587-94
7650389
J Biomol NMR. 1995 Sep;6(2):135-40
8589602
Biochemistry. 1995 Oct 10;34(40):12983-90
7548056
J Biol Chem. 1999 Apr 23;274(17):11768-72
10206993
J Biol Chem. 1996 Apr 19;271(16):9579-86
8621632
FEBS Lett. 1994 Jan 24;338(1):93-7
8307164
Protein Sci. 1997 Mar;6(3):598-608
9070442